Regulatory Agency for Medicines and Health Products (MHRA) British drug regulator has allayed fears of Bell’s palsy associated with a coronavirus vaccine developed by Pfizer-BioNTech after four participants in US trials suffered from facial paralysis
The vaccine was developed by US pharmaceutical company Pfizer and German biotechnology company BioNTech.
According to healthfeedback.org, “four cases in the vaccine group do not represent a frequency above that expected in the general population.”
“Even in an unvaccinated population, a certain number of deaths and cases of Bell’s palsy are expected only by chance. The incidence of Bell’s death and paralysis seen in vaccine participants is not higher than the expected background rate, indicating that most likely no cause relation to the vaccine, ”added healthfeedback.org.
MHRA also made similar observations saying that the safety profile of Pfizer vaccine is similar to other types of routinely used inoculations. The British regulator has stated that it will never allow the delivery of any vaccine in the country that does not meet the required safety, quality and efficacy standards.
It is noteworthy that Pfizer chief Albert Bourla said on December 9 that the farm giant had not “cut any corners” during the expulsion of the vaccines.
The vaccine “was examined just as we test any vaccine circulating there,” Bourla claimed, adding, “this vaccine was actually tested, because of the examination, with even higher standards of how we do things.”
“There are always people who are skeptical about vaccines, but I have to say they are wrong,” the Pfizer CEO said.